Genomics One signs agreement with french company ABIONIX

05-Apr-2005 - Genomics One Corporation announced that it had signed a co-development and co-distribution agreement in the field of Mass Spectrometry with ABIONIX S.a.r.l., a Company based in France. The Corporation also announced that it has entered into a financing agreement with Swiss-based Capital Système ...

Agilent Technologies introduces industry's first HPLC-chip/MS system for proteomics

25-Feb-2005 - Agilent Technologies Inc. introduced the first high-performance liquid chromatography (HPLC)- chip/mass spectrometry (MS) system for protein identification. This breakthrough microfluidics-based LC/MS technology is expected to significantly increase the speed, ease and productivity of proteomics ...

Labcyte Granted Patent for Acoustically Depositing Droplets on a Surface Prior to High Resolution Analysis

17-Feb-2005 - Labcyte Inc. that it has been granted its 17th patent describing the deposition of droplets of low volatility fluids onto surfaces as a precursor to analyses. This technology facilitates higher-resolution imaging by delivering reagents in small droplets of fluids less prone to evaporation. One ...

ICAT Proteomics Technology Reveals Connection Between Two Cellular Structures

Both Structures Defective in Human Cancers

22-Nov-2004 - A combination of novel techniques for identifying key proteins and imaging their localization in cells is proving to be powerful method for unraveling possible mechanisms underlying cancerous growth. In the November issue of Molecular Cell, researchers at the Institute for Systems Biology (ISB) ...

Baylor College of Medicine Uses SEQUENOM's MassARRAY(R) System to Develop Improved Genetic Testing for Cystic Fibrosis

12-Nov-2004 - SEQUENOM, Inc. reported that clinicians at the Baylor College of Medicine have published the successful implementation of the MassARRAY(R) system for high-throughput CFTR testing. The publication in the September/October 2004 issue of Genetics IN Medicine also reports the discovery of a new ...

NeoGenesis Pharmaceuticals Announces Major Breakthrough in Drug Discovery Technology

New technique for affinity measurement in mixtures of chemical compounds allows researchers to optimize drug leads with increased speed and greater mechanistic insight

10-Nov-2004 - Cambridge. NeoGenesis Pharmaceuticals, Inc. announced that they have demonstrated a new, powerful drug discovery technology for evaluating and optimizing the affinities of lead compounds for disease-associated protein targets. In a study published in the Journal of the American ...

Enzyme tests with peptide chips and mass spectrometry

05-Nov-2004 - Cell division, differentiation, programmed cell death-there isn't a single essential cellular process for which protein kinases, enzymes that attach phosphate groups to proteins, haven't assumed important regulatory functions. Knowledge about the activities of the various members of this class ...

Isis Pharmaceuticals Singapore opens lab in the state-of-the-art Biopolis Center for biomedical sciences

13-Oct-2004 - The Helios Block, Biopolis, Singapore. In conjunction with the BioMedical Asia 2004 conference, Isis Pharmaceuticals, Inc., the world's leader in RNA-based drug discovery and development, announced today it has officially opened its research lab in Singapore's Biopolis biomedical sciences center. ...

Emerging Technologies in Lab-on-a-Chip: Microfluidics and µTAS

Key Developments in Microfluidics and µTAS Accelerates the Commercial Acceptance of Lab-on-a-chip Technology

30-Sep-2004 - London, UK. Lab-on-a-chip (LOC) development has skyrocketed in the last couple of years due to constant efforts in harnessing microfluidics and µTAS to improve the LOC design and function. The distinct advantages that they bestow on applications are pushing the commercial potential of ...

PerkinElmer Announces Agreement with Predictive Diagnostics That Allows for Comprehensive Biomarker Platform

New Biomarker Platform Critical In Accelerating Drug Development

14-Sep-2004 - PerkinElmer Inc. andPredictive Diagnostics, Inc. (PDI) announced they have entered into a collaborative partnership for advanced biomarker discovery technology to accelerate drug development and diagnostic testing. Under the terms of the agreement, PerkinElmer will provide access to PDI's ...